Clinical trial
Observational Study Evaluating Subcutaneous LDp/CDp Solution for Infusion Effectiveness on Sleep Disturbances in Advanced Parkinson's Disease
NCT07284342 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study Evaluating Subcutaneous LDp/CDp Solution for Infusion Effectiveness on Sleep Disturbances in Advanced Parkinson's Disease
- Lead sponsor
- AbbVie
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 17, 2025
- Completion date
- January 31, 2027
- Enrollment
- 103 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
advanced parkinson's disease